Pendal Group’s Globus Medical GMED Stock Holding History

Pendal Group’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,200	Closed	-$321K	–	577
2021 Q1	$321K	Buy	5,200 +800	+18%	+$50.7K	﹤0.01%	474
2020 Q4	$287K	Buy	+4,400	New	+$253K	﹤0.01%	439

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Pendal Group's GMED Position: Q2 2021 in Review

Pendal Group sold out of Globus Medical (GMED) in Q2 2021, closing a stake of 5,200 shares — an estimated $321K sold.

Pendal Group first reported a position in GMED in Q4 2020 and held it in 2 quarters. The position peaked at $321K in Q1 2021. 354 funds tracked by Wall St. Rank hold GMED as of Q2 2021.

Pendal Group reported no remaining Globus Medical position as of Q2 2021 after selling out during the quarter.
Pendal Group sold 5,200 Globus Medical shares in Q2 2021, an estimated $321K.
Pendal Group first reported a position in Globus Medical in Q4 2020 and held it in 2 quarters.
Pendal Group's Globus Medical position peaked at $321K in Q1 2021.
354 funds tracked by Wall St. Rank held Globus Medical as of Q2 2021.

Based on Pendal Group's 13F filing for Q2 2021, filed 28 Jul 2021.